Homology Medicines Announces Upcoming Presentation on
- Multiple Presentations Feature HMI-103 Phase 1 Investigational Therapy for PKU, Including Genome-Wide Integration Assays to Confirm No Off-Target Editing...
Source: globenewswire.com
Stay updated with breaking news from Presentations Feature. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Multiple Presentations Feature HMI-103 Phase 1 Investigational Therapy for PKU, Including Genome-Wide Integration Assays to Confirm No Off-Target Editing...